Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Cervical Cancer

  Free Subscription


22.07.2019

1 Acta Obstet Gynecol Scand
1 Ann Epidemiol
1 Ann Transl Med
1 Asian Pac J Cancer Prev
1 Biologicals
2 BMC Public Health
2 BMC Womens Health
1 BMJ Open
1 Bull Exp Biol Med
2 Cancer Biomark
1 Cancer Cell Int
1 Cancer Manag Res
1 Cancer Med
1 Ceska Gynekol
1 Clin Obstet Gynecol
1 CMAJ
1 Contemp Clin Trials
1 Eur J Obstet Gynecol Reprod Biol
1 Eur J Radiol
1 Exp Ther Med
1 Expert Opin Biol Ther
1 Food Chem Toxicol
1 Gynecol Oncol
1 Gynecol Oncol Rep
1 Int J Cancer
2 Int J Clin Oncol
1 Int J Gynecol Cancer
1 Isr Med Assoc J
1 J Cancer Res Ther
2 J Gen Intern Med
1 J Med Syst
1 J Pediatr Adolesc Gynecol
1 JAMA
1 Jpn J Clin Oncol
1 Mediators Inflamm
1 Medicina (Kaunas)
1 Mol Cell
1 Mol Med Rep
1 Mymensingh Med J
1 Oncotarget
1 PLoS One
1 Sao Paulo Med J
1 Strahlenther Onkol
1 Taiwan J Obstet Gynecol
1 Ther Adv Med Oncol
1 Transl Oncol
1 Virchows Arch
1 Zhonghua Yi Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Obstet Gynecol Scand

  1. JORGENSEN SF, Njor SH
    Higher cervical cancer mortality among older women in Denmark could be due to insufficient screening coverage.
    Acta Obstet Gynecol Scand. 2019 Jul 19. doi: 10.1111/aogs.13685.
    PubMed     Text format     Abstract available


    Ann Epidemiol

  2. FOKOM DOMGUE J, Cunningham SA, Yu RK, Shete S, et al
    Prevalence and determinants of cervical cancer screening with a combination of cytology and human papillomavirus testing.
    Ann Epidemiol. 2019 Jun 21. pii: S1047-2797(19)30135.
    PubMed     Text format     Abstract available


    Ann Transl Med

  3. MA J, Yu L, Xu F, Yi H, et al
    Treatment and clinical outcomes of cervical cancer during pregnancy.
    Ann Transl Med. 2019;7:241.
    PubMed     Text format     Abstract available


    Asian Pac J Cancer Prev

  4. RATREE S, Kleebkaow P, Aue-Aungkul A, Temtanakitpaisan A, et al
    Histopathology of Women with "Atypical Squamous Cells Cannot Exclude High-Grade Squamous Intraepithelial Lesion" (ASC-H) Smears
    Asian Pac J Cancer Prev. 2019;20:683-686.
    PubMed     Text format     Abstract available


    Biologicals

  5. KOVACEVIC G, Milosevic V, Knezevic P, Knezevic A, et al
    Prevalence of oncogenic Human papillomavirus and genetic diversity in the L1 gene of HPV16 HPV 18 HPV31 and HPV33 found in women from Vojvodina Province Serbia.
    Biologicals. 2019;58:57-63.
    PubMed     Text format     Abstract available


    BMC Public Health

  6. LIU CR, Liang H, Zhang X, Pu C, et al
    Effect of an educational intervention on HPV knowledge and attitudes towards HPV and its vaccines among junior middle school students in Chengdu, China.
    BMC Public Health. 2019;19:488.
    PubMed     Text format     Abstract available

  7. LORENZI NPC, Termini L, Longatto Filho A, Tacla M, et al
    Age-related acceptability of vaginal self-sampling in cervical cancer screening at two university hospitals: a pilot cross-sectional study.
    BMC Public Health. 2019;19:963.
    PubMed     Text format     Abstract available


    BMC Womens Health

  8. MARLOW L, McBride E, Varnes L, Waller J, et al
    Barriers to cervical screening among older women from hard-to-reach groups: a qualitative study in England.
    BMC Womens Health. 2019;19:38.
    PubMed     Text format     Abstract available

  9. PALUKU JL, Carter TE, Lee M, Bartels SA, et al
    Massive single visit cervical pre-cancer and cancer screening in eastern Democratic Republic of Congo.
    BMC Womens Health. 2019;19:43.
    PubMed     Text format     Abstract available


    BMJ Open

  10. ASGARY R, Cole H, Adongo P, Nwameme A, et al
    Acceptability and implementation challenges of smartphone-based training of community health nurses for visual inspection with acetic acid in Ghana: mHealth and cervical cancer screening.
    BMJ Open. 2019;9:e030528.
    PubMed     Text format     Abstract available


    Bull Exp Biol Med

  11. BUNYATYAN ND, Oborotova NA, Nikolaeva LL, Saprykina NS, et al
    Comparative Analysis of Bioactivity of the Russian-Made Antitumor Substances of the Nitrosourea Group.
    Bull Exp Biol Med. 2019;166:456-460.
    PubMed     Text format     Abstract available


    Cancer Biomark

  12. WU Y, Zhao J, Dong S, Wang Y, et al
    Whole-exome and RNA sequencing reveals novel insights into the pathogenesis of HPV associated cervical cancer.
    Cancer Biomark. 2019 Jun 27. pii: CBM190055. doi: 10.3233/CBM-190055.
    PubMed     Text format     Abstract available

  13. ZHU P, Tan Q, Jiang W, Ou Y, et al
    Eukaryotic translation initiation factor 3B is overexpressed and correlates with higher FIGO stage III/IV, lymph node metastasis and unfavorable survival profiles in cervical cancer patients.
    Cancer Biomark. 2019 Jul 10. pii: CBM182114. doi: 10.3233/CBM-182114.
    PubMed     Text format     Abstract available


    Cancer Cell Int

  14. ZHANG J, Gao Y
    Long non-coding RNA MEG3 inhibits cervical cancer cell growth by promoting degradation of P-STAT3 protein via ubiquitination.
    Cancer Cell Int. 2019;19:175.
    PubMed     Text format     Abstract available


    Cancer Manag Res

  15. DENG YR, Chen XJ, Chen W, Wu LF, et al
    Sp1 contributes to radioresistance of cervical cancer through targeting G2/M cell cycle checkpoint CDK1.
    Cancer Manag Res. 2019;11:5835-5844.
    PubMed     Text format     Abstract available


    Cancer Med

  16. WU MF, Guan MM, Liu CH, Wu JY, et al
    The added value of fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant chemotherapy followed by radical hysterectomy.
    Cancer Med. 2019 Jul 16. doi: 10.1002/cam4.2414.
    PubMed     Text format     Abstract available


    Ceska Gynekol

  17. PICHLIK T, Rob L, Robova H, Halaska MJ, et al
    Individualization of surgical management of cervical cancer stages IA1, IA2.
    Ceska Gynekol. 2019;84:172-176.
    PubMed     Text format     Abstract available


    Clin Obstet Gynecol

  18. BUS-KWOFIE A, Chan C, Kahn R, Holcomb K, et al
    Clinical Controversies in Cervical Cancer Screening.
    Clin Obstet Gynecol. 2019 Jul 11. doi: 10.1097/GRF.0000000000000478.
    PubMed     Text format     Abstract available


    CMAJ

  19. KRAUT RY
    Starting cervical cancer screening at 25 years of age.
    CMAJ. 2019;191:E797.
    PubMed     Text format    


    Contemp Clin Trials

  20. WINER R, Tiro JA, Miglioretti DL, Thayer C, et al
    Corrigendum to "Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system" [Cont
    Contemp Clin Trials. 2019 Jul 13:105811. doi: 10.1016/j.cct.2019.
    PubMed     Text format    


    Eur J Obstet Gynecol Reprod Biol

  21. AYHAN A, Aslan K, Bulut AN, Akilli H, et al
    Is the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previously staged as IB disease?
    Eur J Obstet Gynecol Reprod Biol. 2019;240:209-214.
    PubMed     Text format     Abstract available


    Eur J Radiol

  22. XU C, Sun H, Du S, Xin J, et al
    Early treatment response of patients undergoing concurrent chemoradiotherapy for cervical cancer: An evaluation of integrated multi-parameter PET-IVIM MR.
    Eur J Radiol. 2019;117:1-8.
    PubMed     Text format     Abstract available


    Exp Ther Med

  23. SUN Y, Cheng Y, Zhang Y, Han K, et al
    MicroRNA-889-3p targets FGFR2 to inhibit cervical cancer cell viability and invasion.
    Exp Ther Med. 2019;18:1440-1448.
    PubMed     Text format     Abstract available


    Expert Opin Biol Ther

  24. MARRET G, Borcoman E, Le Tourneau C
    Pembrolizumab for the treatment of Cervical Cancer.
    Expert Opin Biol Ther. 2019 Jul 19. doi: 10.1080/14712598.2019.1646721.
    PubMed     Text format     Abstract available


    Food Chem Toxicol

  25. POTOCNJAK I, Simic L, Vukelic I, Domitrovic R, et al
    Oleanolic acid attenuates cisplatin-induced nephrotoxicity in mice and chemosensitizes human cervical cancer cells to cisplatin cytotoxicity.
    Food Chem Toxicol. 2019;132:110676.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  26. LIU B, Li L, Wang M, Wei L, et al
    Health-related quality of life in locally advanced cervical cancer patients treated with neoadjuvant therapy followed by radical surgery: A single-institutional retrospective study from a prospective database.
    Gynecol Oncol. 2019 Jul 12. pii: S0090-8258(19)31354.
    PubMed     Text format     Abstract available


    Gynecol Oncol Rep

  27. RUNGE AS, Bernstein ME, Lucas AN, Tewari KS, et al
    Cervical cancer in Tanzania: A systematic review of current challenges in six domains.
    Gynecol Oncol Rep. 2019;29:40-47.
    PubMed     Text format     Abstract available


    Int J Cancer

  28. TAWE L, MacDuffie E, Narasimhamurthy M, Wang Q, et al
    Human Papillomavirus (HPV) Genotypes in Women with Invasive Cervical Cancer with and without Human Immunodeficiency Virus (HIV) Infection in Botswana.
    Int J Cancer. 2019 Jul 20. doi: 10.1002/ijc.32581.
    PubMed     Text format     Abstract available


    Int J Clin Oncol

  29. LI L, Wu M, Ma S, Tan X, et al
    Neoadjuvant chemotherapy followed by radical hysterectomy for stage IB2-to-IIB cervical cancer: a retrospective cohort study.
    Int J Clin Oncol. 2019 Jul 15. pii: 10.1007/s10147-019-01510.
    PubMed     Text format     Abstract available

  30. CHAY DB, Han GH, Nam S, Cho H, et al
    Forkhead box protein O1 (FOXO1) and paired box gene 3 (PAX3) overexpression is associated with poor prognosis in patients with cervical cancer.
    Int J Clin Oncol. 2019 Jul 13. pii: 10.1007/s10147-019-01507.
    PubMed     Text format     Abstract available


    Int J Gynecol Cancer

  31. COLA E, Maziku D, Torelli GF, Fagotti A, et al
    Cervical cancer in Tosamaganga Hospital, Tanzania: difficulties and challenges in a low resource country setting.
    Int J Gynecol Cancer. 2019 Jul 19. pii: ijgc-2019-000505.
    PubMed     Text format    


    Isr Med Assoc J

  32. NAMAZOV A, Volchok V, Liboff A, Volodarsky M, et al
    Sentinel Nodes Detection with Near-infrared Imaging in Gynecological Cancer Patients: Ushering in an Era of Precision Medicine.
    Isr Med Assoc J. 2019;21:390-393.
    PubMed     Text format     Abstract available


    J Cancer Res Ther

  33. NADERI J, Samani F, Amooheidari A, Javanmard SH, et al
    Evaluation of effects of morphine and ionizing radiation in cancer cell lines.
    J Cancer Res Ther. 2019;15.
    PubMed     Text format     Abstract available


    J Gen Intern Med

  34. CHEN T, Wei M, Liu Y, Wang H, et al
    Rising Mortality Rate of Cervical Cancer in Younger Women in Urban China.
    J Gen Intern Med. 2019 Jul 15. pii: 10.1007/s11606-019-05174.
    PubMed     Text format    

  35. OGDEN SN, Glanz K, Schapira MM, Bocage C, et al
    Patient Perspectives on Primary HPV Testing for Routine Cervical Cancer Screening.
    J Gen Intern Med. 2019 Jul 16. pii: 10.1007/s11606-019-05175.
    PubMed     Text format    


    J Med Syst

  36. GEETHA R, Sivasubramanian S, Kaliappan M, Vimal S, et al
    Cervical Cancer Identification with Synthetic Minority Oversampling Technique and PCA Analysis using Random Forest Classifier.
    J Med Syst. 2019;43:286.
    PubMed     Text format     Abstract available


    J Pediatr Adolesc Gynecol

  37. SPELLUN AH, Moreland CJ, Kushalnagar P
    Young Deaf Adults' Knowledge of Human Papillomavirus and Human Papillomavirus Vaccine's Effectiveness in Preventing Cervical, Anal, Penile, and Oral Cancer.
    J Pediatr Adolesc Gynecol. 2019;32:293-299.
    PubMed     Text format     Abstract available


    JAMA

  38. KUEHN B
    Reducing Cervical Cancer Deaths.
    JAMA. 2019;322:198.
    PubMed     Text format    


    Jpn J Clin Oncol

  39. NIIKURA H, Tsuji K, Tokunaga H, Shimada M, et al
    Sentinel node navigation surgery in cervical and endometrial cancer: a review.
    Jpn J Clin Oncol. 2019;49:495-500.
    PubMed     Text format     Abstract available


    Mediators Inflamm

  40. CHEN Z, Zhu Y, Du R, Pang N, et al
    Role of Regulatory B Cells in the Progression of Cervical Cancer.
    Mediators Inflamm. 2019;2019:6519427.
    PubMed     Text format     Abstract available


    Medicina (Kaunas)

  41. BALASUBRAMANIAM SD, Balakrishnan V, Oon CE, Kaur G, et al
    Key Molecular Events in Cervical Cancer Development.
    Medicina (Kaunas). 2019;55.
    PubMed     Text format     Abstract available


    Mol Cell

  42. GARCIA-MORENO M, Noerenberg M, Ni S, Jarvelin AI, et al
    System-wide Profiling of RNA-Binding Proteins Uncovers Key Regulators of Virus Infection.
    Mol Cell. 2019;74:196-211.
    PubMed     Text format     Abstract available


    Mol Med Rep

  43. WANG C, Zou H, Yang H, Wang L, et al
    Long noncoding RNA plasmacytoma variant translocation 1 gene promotes the development of cervical cancer via the NFkappaB pathway.
    Mol Med Rep. 2019 Jul 9. doi: 10.3892/mmr.2019.10479.
    PubMed     Text format     Abstract available


    Mymensingh Med J

  44. ABEDIN S, Paul SK, Haque N, Ahmed S, et al
    Distribution of HPV-16 and HPV-18 from the Patients Attending At Mymensingh Medical College Hospital by Newly Developed Oncoprotein Detection Assay.
    Mymensingh Med J. 2019;28:31-36.
    PubMed     Text format     Abstract available


    Oncotarget

  45. CHIZENGA EP, Chandran R, Abrahamse H
    Photodynamic therapy of cervical cancer by eradication of cervical cancer cells and cervical cancer stem cells.
    Oncotarget. 2019;10:4380-4396.
    PubMed     Text format     Abstract available


    PLoS One

  46. YU W, Kou C, Bai W, Yu X, et al
    The diagnostic performance of PET/CT scans for the detection of para-aortic metastatic lymph nodes in patients with cervical cancer: A meta-analysis.
    PLoS One. 2019;14:e0220080.
    PubMed     Text format     Abstract available


    Sao Paulo Med J

  47. YORUK S, Acikgoz A, Turkmen H, Ergor G, et al
    Risk factors and relationship between screening periodicity and risk of cervical cancer among nurses and midwives. A cross-sectional study.
    Sao Paulo Med J. 2019;137:119-125.
    PubMed     Text format     Abstract available


    Strahlenther Onkol

  48. VOJTISEK R, Sukovska E, Baxa J, Budikova M, et al
    Late side effects of 3T MRI-guided 3D high-dose rate brachytherapy of cervical cancer : Institutional experiences.
    Strahlenther Onkol. 2019 Jul 15. pii: 10.1007/s00066-019-01491.
    PubMed     Text format     Abstract available


    Taiwan J Obstet Gynecol

  49. NUTTHACHOTE P, Oranratanaphan S, Termrungruanglert W, Triratanachat S, et al
    Comparison of detection rate of high risk HPV infection between self-collected HPV testing and clinician-collected HPV testing in cervical cancer screening.
    Taiwan J Obstet Gynecol. 2019;58:477-481.
    PubMed     Text format     Abstract available


    Ther Adv Med Oncol

  50. SUN Y, Feng Y, Zhang G, Xu Y, et al
    The endonuclease APE1 processes miR-92b formation, thereby regulating expression of the tumor suppressor LDLR in cervical cancer cells.
    Ther Adv Med Oncol. 2019;11:1758835919855859.
    PubMed     Text format     Abstract available


    Transl Oncol

  51. JIANG Z, Albanese J, Kesterson J, Warrick J, et al
    Monoclonal Antibodies Against Human Papillomavirus E6 and E7 Oncoproteins Inhibit Tumor Growth in Experimental Cervical Cancer.
    Transl Oncol. 2019;12:1289-1295.
    PubMed     Text format     Abstract available


    Virchows Arch

  52. MAKK E, Balint L, Cifra J, Tornoczky T, et al
    Robust expression of EZH2 in endocervical neoplastic lesions.
    Virchows Arch. 2019;475:95-104.
    PubMed     Text format     Abstract available


    Zhonghua Yi Xue Za Zhi

  53. WANG SF, Bu QW, Zhang L, Ma JW, et al
    [Detection and analysis of FAM19A4 promoter methylation in cervical exfoliated cells].
    Zhonghua Yi Xue Za Zhi. 2019;99:1963-1967.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: